MAXIMUS (MMS) Upgraded by Zacks Investment Research to “Hold”

Zacks Investment Research upgraded shares of MAXIMUS (NYSE:MMS) from a sell rating to a hold rating in a research report sent to investors on Wednesday.

According to Zacks, “MAXIMUS, Inc. is an extremely dynamic and complex organization that offers government and industry a range of unique services, products, and solutions. The diverse services and products that MAXIMUS offers may be categorized into three groups: Government Program Management and Operations, Consulting, and Systems. Government Program Management and Operations focuses on having a measurable impact on the lives of the citizens we help government serve. The insights of MAXIMUS Consulting, and the technological innovations advanced through Systems, help government gain program efficiencies and pursue improvements that in turn benefit citizens. “

Separately, Canaccord Genuity reiterated a buy rating on shares of MAXIMUS in a research note on Wednesday, December 27th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has assigned a buy rating to the company’s stock. The stock has a consensus rating of Hold and a consensus price target of $65.60.

Shares of MAXIMUS (NYSE:MMS) traded down $0.39 during trading on Wednesday, reaching $69.58. The company had a trading volume of 483,713 shares, compared to its average volume of 435,967. MAXIMUS has a 12 month low of $51.74 and a 12 month high of $72.71. The stock has a market cap of $4,640.98, a PE ratio of 21.88, a price-to-earnings-growth ratio of 2.67 and a beta of 1.34.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 28th. Stockholders of record on Thursday, February 15th will be paid a $0.045 dividend. This represents a $0.18 annualized dividend and a dividend yield of 0.26%. The ex-dividend date is Wednesday, February 14th. MAXIMUS’s payout ratio is presently 5.66%.

In other news, CEO Richard A. Montoni sold 30,000 shares of MAXIMUS stock in a transaction dated Thursday, December 7th. The stock was sold at an average price of $69.25, for a total value of $2,077,500.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, General Counsel David Francis sold 3,900 shares of MAXIMUS stock in a transaction dated Monday, November 13th. The shares were sold at an average price of $63.97, for a total value of $249,483.00. Following the completion of the transaction, the general counsel now owns 15,090 shares of the company’s stock, valued at approximately $965,307.30. The disclosure for this sale can be found here. Insiders sold a total of 71,417 shares of company stock valued at $4,902,785 in the last quarter. Company insiders own 3.10% of the company’s stock.

Institutional investors and hedge funds have recently made changes to their positions in the company. Acrospire Investment Management LLC boosted its stake in shares of MAXIMUS by 17.6% in the 2nd quarter. Acrospire Investment Management LLC now owns 2,000 shares of the health services provider’s stock valued at $125,000 after buying an additional 300 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of MAXIMUS by 10.2% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,367 shares of the health services provider’s stock worth $148,000 after acquiring an additional 220 shares in the last quarter. Intl Fcstone Inc. acquired a new stake in shares of MAXIMUS during the 2nd quarter worth about $201,000. OLD National Bancorp IN acquired a new stake in shares of MAXIMUS during the 3rd quarter worth about $246,000. Finally, Cubist Systematic Strategies LLC raised its position in shares of MAXIMUS by 16.0% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 3,969 shares of the health services provider’s stock worth $249,000 after acquiring an additional 546 shares in the last quarter. Institutional investors and hedge funds own 94.79% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “MAXIMUS (MMS) Upgraded by Zacks Investment Research to “Hold”” was originally reported by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this report on another publication, it was copied illegally and republished in violation of United States and international copyright and trademark legislation. The original version of this report can be read at https://stocknewstimes.com/2018/01/18/maximus-mms-upgraded-by-zacks-investment-research-to-hold.html.

MAXIMUS Company Profile

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply